misleading statements

Concorde International Group Ltd. ($CIGL) faces securities class action lawsuit alleging fraud involving social media misinformation, insider share sales, and artificial trading. Investors have until May 20, 2026 to secure counsel.

Securities lawsuit filed against $ATRA over alleged false statements on manufacturing issues and ALLELE study deficiencies affecting tabelecleucel approval prospects.

Class action lawsuit filed against Boston Scientific for allegedly concealing unsustainable growth in U.S. Electrophysiology segment. Affected investors have until May 4, 2026 deadline.

Rosen Law Firm sues Aldeyra Therapeutics for false reproxalap trial claims. Lead plaintiff deadline: May 29, 2026.

Robbins LLP files class action against Alight Inc. ($ALIT) for alleged misrepresentation of financial stability and growth prospects, following 38% single-day collapse and dividend cancellation.

Rosen Law Firm sues Picard Medical ($PMI) for alleged stock manipulation involving social media fraud and insider dumping. Investors with $100K+ losses have until April 13, 2026 deadline.

ODDITY Tech ($ODD) faces class action lawsuit over undisclosed algorithm changes from major ad partner that inflated customer acquisition costs, triggering 49% stock plunge.

Hagens Berman files securities class action against Kyndryl for allegedly manipulating free cash flow metrics. Stock plummeted 55% after SEC investigation disclosure and executive departures.

Class action lawsuit filed against $UPST for allegedly concealing AI model flaws. November reveal of weak Q3 results triggered sharp stock decline, sparking shareholder claims.

Class action lawsuit filed against $PSIX alleging false statements about data center demand and manufacturing capacity costs. Lead plaintiff deadline May 19, 2026.

Class action filed against $ALDYA alleging false statements about reproxalap trial results. Eligible investors covered Nov 2023-Mar 2026.

Class action lawsuit filed against $SNOW for allegedly concealing negative revenue impact of product efficiency features. Investors have until April 2026 deadline.

Rosen Law Firm urges $CIGL investors to act before May 20, 2026 lead plaintiff deadline in securities class action alleging false statements and fraudulent stock promotion.

Class action lawsuit filed against $STLA for alleged misstatements on electrification prospects. February 2026 €22.2B reset triggered 23% stock decline; lead plaintiffs sought.

Law firm Levi & Korsinsky files class action against Medpace Holdings over alleged false statements about backlog cancellations. Stock fell 15.9% after disappointing Q4 guidance.

Class action lawsuit filed against Corcept Therapeutics alleging securities fraud over misleading statements about relacorilant clinical trials and FDA approval prospects.

Rosen Law Firm urges $PMI investors to join class action alleging false statements, social media misinformation, and insider share dumping. Lead plaintiff deadline: April 13, 2026.

Class action filed against $POM alleges materially false statements, social media misinformation, insider dumping, and artificial trading. Investors have until April 7, 2026 to seek lead plaintiff status.

Grocery Outlet faces securities lawsuit alleging CEO and CFO certified false statements about store expansion and profitability, triggering 27.9% stock plunge.

Class action filed against $ENPH for allegedly concealing operational problems behind generic risk warnings while manipulating revenue and overstating tax credit mitigation.